Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Aug 6, 2026 · most recent call
RMD’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: ResMed’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: RMD daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.
On August 13, 2026, ResMed's Audit Committee dismissed KPMG LLP as its independent registered public accounting firm and appointed PricewaterhouseCoopers LLP for the fiscal year ending June 30, 2027, following a competitive review. KPMG's reports for fiscal 2026 and 2025 contained no adverse or qualified opinions, and there were no disagreements or reportable events.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2025 Q1 | $1.22B | +11.1% | $2.11 | +41.6% | 58.6% | 31.6% | 25.4% | $306M |
| FY2025 Q2 | $1.28B | +10.3% | $2.34 | +64.8% | 58.6% | 32.5% | 26.9% | $290M |
| FY2025 Q3 | $1.29B | +7.9% | $2.48 | +21.6% | 59.3% | 33.0% | 28.3% | $555M |
| FY2025 Q4 | $1.35B | +10.2% | $2.58 | +30.3% | 60.8% | 33.7% | 28.2% | $508M |
| FY2026 Q1 | $1.34B | +9.1% | $2.37 | +12.3% | 61.5% | 33.4% | 26.1% | $414M |
| FY2026 Q2 | $1.42B | +11.0% | $2.68 | +14.5% | 62.2% | 34.6% | 27.6% | $305M |
| FY2026 Q3 | $1.43B | +10.8% | $2.74 | +10.5% | 62.2% | 34.9% | 27.9% | $520M |
| FY2026 Q4Selected | $1.46B | +8.6% | $2.64 | +2.3% | 58.8% | 30.7% | 26.2% | $1.65B |
| Year | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2023 | $4.22B | +18.0% | $6.10 | +14.9% | 55.8% | 26.8% | 21.3% | $559M |
| FY2024 | $4.69B | +10.9% | $6.93 | +13.6% | 56.7% | 28.2% | 21.8% | $1.29B |
| FY2025 | $5.15B | +9.8% | $9.51 | +37.2% | 59.4% | 32.7% | 27.2% | $1.66B |
| FY2026Selected | $5.65B | +9.9% | $10.43 | +9.7% | 61.2% | 33.4% | 26.9% | $2.89B |
Management-stated figures from RMD’s newest call are part of Tellvest Pro.